PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction.

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We…